BRISTOL-MYERS SQUIBB COMPANY Capitalized Computer Software, Additions
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Capitalized Computer Software, Additions of $80.00 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-14.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:CapitalizedComputerSoftwareAdditions · last filed 2014-02-14
- BRISTOL-MYERS SQUIBB COMPANY capitalized computer software, additions for the quarter ending 2012-12-31 was $16.00M, a 23.81% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY capitalized computer software, additions for the quarter ending 2011-12-31 was $21.00M.
- BRISTOL-MYERS SQUIBB COMPANY capitalized computer software, additions for fiscal 2013 was $80.00M, a 33.33% increase from fiscal 2012.
- BRISTOL-MYERS SQUIBB COMPANY capitalized computer software, additions for fiscal 2012 was $60.00M, a 20.00% decline from fiscal 2011.
- BRISTOL-MYERS SQUIBB COMPANY capitalized computer software, additions for fiscal 2011 was $75.00M, a 29.91% decline from fiscal 2010.
- BRISTOL-MYERS SQUIBB COMPANY capitalized computer software, additions for fiscal 2010 was $107.00M, a 11.46% increase from fiscal 2009.
| Period end | Capitalized Computer Software, Additions 3 month | Capitalized Computer Software, Additions 9 month | Capitalized Computer Software, Additions 12 month |
|---|---|---|---|
| 2013-12-31 | $80.00M 10-K · filed 2014-02-14 | ||
| 2012-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | $60.00M 10-K · filed 2014-02-14 | |
| 2012-09-30 | $44.00M 10-Q · filed 2012-10-24 | ||
| 2011-12-31 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | $75.00M 10-K · filed 2014-02-14 | |
| 2011-09-30 | $54.00M 10-Q · filed 2012-10-24 | ||
| 2010-12-31 | $107.00M 10-K · filed 2013-02-15 | ||
| 2009-12-31 | $96.00M 10-K · filed 2012-02-17 | ||
| 2008-12-31 | $138.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |